Skip to main content
    V

    Venus Concept Inc (VERO)

    Official site

    MEDICAL DEVICES

    $0.31
    +0.00 (+0.00%)

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    28%(9/32)
    Avg Surprise
    -245.58%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 13
    		$-12.14$-0.28-4235.71%Miss-905.0%
    Jun 25
    Reported Aug 14
    		$-8.03$-0.27-2874.07%Miss-163.3%
    Mar 25
    Reported May 15
    		$-11.23$-14.62+23.16%Beat-568.7%
    Dec 24
    Reported Mar 31
    		$-11.23$-10.01-12.19%Miss-458.7%
    Sep 24
    Reported Nov 13
    		$-1.21$-1.20-0.67%Miss+26.3%
    Jun 24
    Reported Aug 13
    		$-3.05$-1.43-113.29%Miss-125.9%
    Mar 24
    Reported Apr 1
    		$-1.68$-1.53-9.80%Miss+9.2%
    Dec 23
    Reported Feb 13
    		$-2.01$-1.18-70.34%Miss-1335.7%
    Sep 23
    Reported Nov 14
    		$-1.64$-1.51-8.61%Miss-645.5%
    Jun 23
    Reported Aug 14
    		$-1.35$-1.54+12.34%Beat-743.8%
    Mar 23
    Reported May 15
    		$-1.85$-2.12+12.74%Beat-1323.1%
    Dec 22
    Reported Mar 27
    		$-0.14$-0.14+0.00%Beat-75.0%
    Sep 22
    Reported Nov 10
    		$-0.22$-0.15-46.67%Miss-22.2%
    Jun 22
    Reported Aug 12
    		$-0.16$-0.07-128.57%Miss-300.0%
    Mar 22
    Reported May 12
    		$-0.13$-0.09-44.44%Miss+23.5%
    Dec 21
    Reported Mar 28
    		$-0.08$-0.10+20.00%Beat+72.4%
    Sep 21
    Reported Nov 12
    		$-0.18$-0.12-50.00%Miss+0.0%
    Jun 21
    Reported Aug 13
    		$-0.04N/A+66.67%Beat+89.7%
    Mar 21
    Reported May 17
    		$-0.17$-0.15-13.33%Miss+78.2%
    Dec 20
    Reported Mar 29
    		$-0.29$-0.19-52.63%Miss+72.9%
    Sep 20
    Reported Nov 16
    		$-0.18$-0.22+18.18%Beat+94.7%
    Jun 20
    Reported Aug 13
    		$-0.39$-0.37-5.41%Miss+86.3%
    Mar 20
    Reported May 14
    		$-0.78$-0.71-9.86%Miss+71.1%
    Dec 19
    Reported Mar 30
    		$-1.07$-0.41-160.98%Miss+64.3%
    Sep 19
    Reported Nov 14
    		$-3.38$-1.87-80.75%Miss-12.7%
    Jun 19
    Reported Aug 14
    		$-2.85$-2.25-26.67%Miss+9.5%
    Mar 19
    Reported May 15
    		$-2.70$-2.80+3.57%Beat+30.8%
    Dec 18
    Reported Mar 15
    		$-3.00$-2.51-19.52%Miss-66.7%
    Sep 18
    Reported Nov 5
    		$-3.00$-2.60-15.38%Miss+95.1%
    Jun 18
    Reported Jul 30
    		$-3.15$-3.05-3.28%Miss-1650.0%
    Mar 18
    Reported May 14
    		$-3.90$-2.47-57.89%Miss-
    Dec 17
    Reported Mar 5
    		$-1.80$-2.40+25.00%Beat-
    Sep 17
    Reported Nov 21
    		$-61.05N/AN/ABeat-
    Jun 17
    Reported Jul 7
    		$-0.18$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.03xFCF Yield-3594.65%
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROIC-107.77%
    Financial Health
    Debt/Equity11.25xInterest Coverage-1.85x
    Current Ratio0.90xQuick Ratio0.47x
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.31
    SMA 20$0.31
    SMA 50$0.31
    SMA 200$0.53
    EMA 10$0.31
    EMA 20$0.31
    EMA 50$0.31
    EMA 200$0.67

    MACD

    Line: N/ASignal: N/AHist: N/A

    ADX

    ADX: 7.2+DI: 19.6-DI: 22.6

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down100.0
    PSAR$0.32

    Bollinger Bands

    Upper Band$0.31
    Lower Band$0.31
    %B Position0%(Lower)
    Band Width0.50

    RSI (14-Day)

    Neutral
    41.8

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %RN/A
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)N/A
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)N/A(0.0%)
    StdDev (20d)N/A
    Hist VolN/A

    Volume Flow

    VWAP$0.31
    OBV412.2M
    AD Line-204.4M
    CMF (20d)N/A

    Volume Metrics

    Avg Vol (20d)N/A
    Vol RatioN/A
    VWMA (20d)N/A

    Pivot Points

    R3$0.31
    R2$0.31
    R1$0.31
    Pivot Point$0.31
    S1$0.31
    S2$0.31
    S3$0.31

    Advanced Oscillators

    TSI-16.36
    Ultimate OscN/A
    KSTN/A

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$13.78M$15.69M$13.64M$15.77M$15.01M$16.58M$17.48M$18.13M$17.62M$20.07M$20.53M$24.29M
    Cost of Revenue$4.96M$6.26M$4.89M$4.88M$5.09M$4.73M$5.83M$6.07M$5.43M$5.86M$6.83M$8.50M
    Gross Profit$8.82M$9.43M$8.76M$10.89M$9.92M$11.85M$11.65M$12.06M$12.19M$14.22M$13.70M$15.79M
    Operating Expenses$18.31M$18.47M$18.28M$17.56M$17.08M$17.45M$19.41M$19.70M$18.95M$19.98M$21.85M$24.68M
    R&D$1.28M$1.35M$1.56M$1.47M$1.69M$1.74M$1.78M$1.67M$1.93M$1.97M$2.64M$2.57M
    SG&A$9.65M$9.43M$9.73M$8.83M$8.73M$8.66M$10.25M$10.12M$10.12M$9.63M$11.19M$12.80M
    Operating Income$-9,496,000$-9,041,000$-9,528,000$-6,671,000$-7,157,000$-5,596,000$-7,760,000$-7,634,000$-6,762,000$-5,758,000$-8,155,000$-8,889,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$12.31M$3.03M$2.62M$1.10M$2.12M$13.35M$1.67M$4.27M$1.60M$1.55M$1.51M$1.39M
    Income Before Tax$-22,018,000$-11,528,000$-12,028,000$-8,774,000$-9,333,000$-19,723,000$-9,752,000$-11,324,000$-9,277,000$-7,132,000$-9,388,000$-10,754,000
    Income Tax Expense$531,000$214,000$338,000$-758,000$-31,000$141,000$37,000$-174,000$-321,000$189,000$235,000$-814,000
    Net Income$-22,549,000$-11,742,000$-12,366,000$-8,016,000$-9,302,000$-19,864,000$-9,789,000$-11,150,000$-8,956,000$-7,321,000$-9,623,000$-9,940,000
    EBITDA$-7,437,000$-6,439,000$-6,825,000$-5,468,000$-4,618,000$-3,348,000$-6,628,000$-5,088,000$-6,032,000$-3,948,000$-6,799,000$-8,076,000
    EBIT$-9,705,000$-8,496,000$-9,409,000$-7,674,000$-7,214,000$-6,370,000$-8,084,000$-7,057,000$-7,672,000$-5,579,000$-7,880,000$-9,369,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VERO

    News

    No news available

    Company news will appear here when available

    VERO Valuation and Fair Value

    P/FCF
    -0.0x
    P/B
    0.2x
    See GNG's fair value

    VERO Profitability: Margins, ROIC and FCF

    Gross margin
    64.4%
    ROIC
    -107.8%
    FCF margin
    -35.2%
    FCF yield
    -3594.6%

    VERO Competitors

    CompanyTicker
    Profusa, Inc. Common StockPFSA
    CERo Therapeutics Holdings, Inc. Common StockCERO
    SAB Biotherapeutics IncSABSW
    Tivic Health Systems IncTIVC
    GlucoTrack IncGCTK
    Salarius Pharmaceuticals IncSLRX
    Bone Biologics CorpBBLG
    Inotiv IncNOTV

    Sector: Healthcare

    VERO Bull Case vs Bear Case

    Bear case

    • VERO beat EPS estimates in 12.5% of its last 8 reported quarters.
    • VERO has a debt-to-equity ratio of 11.2x.

    VERO Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -911.6%

    Frequently Asked Questions About VERO

    Does VERO pay dividends?

    Venus Concept Inc (VERO) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with V

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In